The Use of Technology to Improve MS Clinical Trials and Patient Care
| Status: | Recruiting |
|---|---|
| Conditions: | Neurology, Multiple Sclerosis |
| Therapuetic Areas: | Neurology, Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/22/2018 |
| Start Date: | July 31, 2018 |
| End Date: | May 31, 2020 |
| Contact: | Ellen Mowry |
| Email: | mscenter@jhmi.edu |
| Phone: | 4106141522 |
Many patients with multiple sclerosis (MS) experience "relapses" of disease activity during
which they have increased numbness, weakness, visual problems, or other symptoms. If a person
with MS has new symptoms that are concerning to them, their doctor may want to see them in
the office in order to confirm that these symptoms are due to a true "relapse" of activity
before starting relapse treatment. This requirement can be frustrating for patients, who may
have to take time off from work or travel long distances for such unexpected doctors' visits.
In this study, the investigators will use input from patients with MS and MS physicians to
create a relapse questionnaire that can be used to confirm a relapse has occurred. The
investigators will also evaluate if having a more direct line of communication with the
provider's office improves overall patient care and satisfaction.
which they have increased numbness, weakness, visual problems, or other symptoms. If a person
with MS has new symptoms that are concerning to them, their doctor may want to see them in
the office in order to confirm that these symptoms are due to a true "relapse" of activity
before starting relapse treatment. This requirement can be frustrating for patients, who may
have to take time off from work or travel long distances for such unexpected doctors' visits.
In this study, the investigators will use input from patients with MS and MS physicians to
create a relapse questionnaire that can be used to confirm a relapse has occurred. The
investigators will also evaluate if having a more direct line of communication with the
provider's office improves overall patient care and satisfaction.
This research is being done to study if a relapse questionnaire for people with multiple
sclerosis (MS) may help more easily determine if a relapse has occurred.
A further goal of this study is to determine if receiving periodic messages from the doctor's
office, as well as having the direct contact information of a person in the office, improves
the care of the patients and their experience thereof.
sclerosis (MS) may help more easily determine if a relapse has occurred.
A further goal of this study is to determine if receiving periodic messages from the doctor's
office, as well as having the direct contact information of a person in the office, improves
the care of the patients and their experience thereof.
Inclusion Criteria:
- English speakers
- Relapsing-remitting MS (2010 criteria)
- Expanded Disability Status Scale (EDSS) ≤6.0
- Possession of a smartphone OR of a mobile telephone with text messaging AND an e-mail
account AND web access OR willingness to be provided with, and utilize, a smartphone
for the duration of the study
- In the two years before screening:
at least two relapses, OR one relapse and two new lesions (unrelated to relapse symptoms)
on magnetic resonance imaging (MRI), OR RRMS (MAGNIMS 2010 criteria) onset within the past
year with no exposure to disease modifying therapies (DMT)
- Patient is starting one of the following MS therapies: injectable (subcutaneous
interferon beta or glatiramer acetate) or oral (fingolimod, teriflunomide, or dimethyl
fumarate) therapies
- Relapse and MRI activity occurred while untreated or despite one single treatment, and
no change in therapy since that activity
- Lives within 100 miles of Johns Hopkins Medical Center (Baltimore, MD)
Exclusion Criteria:
- History of DMT exposure if MAGNIMS 2010 criteria used to enroll patients with disease
onset in the past year, or change in MS therapy since qualifying relapse/MRI criteria
occurred
We found this trial at
1
site
Johns Hopkins University The Johns Hopkins University opened in 1876, with the inauguration of its...
Click here to add this to my saved trials
